NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001551

Registered date:01/02/2009

Analysis for effect of Eicosapentaenoic acid (EPA) on aberrant crypt foci (ACF)

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedSubjects with aberrant crypt foci (ACF)
Date of first enrollment2009/02/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Oral administration of EPA 600mg three times daily for one month. No administration of newly drug for one month.

Outcome(s)

Primary OutcomeObservation of ACF and polyps using magnifying endoscopy
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaa. Liver cirrhosis or chronic hepatic, chronic renal failure b. Women who are pregnant or with a possibility of pregnancy c. Alcohol dependence or drug dependence d. Drug allergy e. Heart failure f. Hemorrhagic g. Those who have started to use other medication or dietary supplement in study period h. The patient that it is already taken EPA i. History of colorectal cancer j. Family history of colorectal cancer k. The patient currently taking NSAIDs l. Inadequate to entry to this study

Related Information

Contact

public contact
Name Hirokazu Takahashi
Address 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Japan Japan
Telephone
E-mail
Affiliation Yokohama City University Graduate School of Medicine Gastroenterology Division
scientific contact
Name Atsushi Nakajima
Address 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Japan Japan
Telephone
E-mail
Affiliation Yokohama City University Graduate School of Medicine Gastroenterology Division